Christopher Brown Sells 9,900 Shares of 908 Devices (NASDAQ:MASS) Stock

908 Devices Inc. (NASDAQ:MASS) Director Christopher Brown sold 9,900 shares of 908 Devices stock in a transaction on Tuesday, June 23rd. The stock was sold at an average price of $9.04, for a total transaction of $89,496.00. Following the completion of the transaction, the director owned 865,559 shares in the company, valued at $7,824,653.36. This trade represents a 1.13% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

908 Devices Stock Up 0.1%

MASS stock traded up $0.01 during mid-day trading on Thursday, reaching $8.98. 398,836 shares of the stock traded hands, compared to its average volume of 298,063. The firm has a market capitalization of $339.53 million, a PE ratio of -8.98 and a beta of 0.63. The business has a 50-day moving average of $7.78 and a two-hundred day moving average of $6.76. 908 Devices Inc. has a 52 week low of $5.03 and a 52 week high of $9.34.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Raymond James Financial Inc. bought a new stake in shares of 908 Devices in the second quarter valued at about $48,000. Intelligence Driven Advisers LLC acquired a new position in 908 Devices in the 1st quarter valued at approximately $61,000. Daiwa Securities Group Inc. acquired a new position in 908 Devices in the 2nd quarter valued at approximately $61,000. PCM Encore LLC bought a new stake in shares of 908 Devices in the 4th quarter worth approximately $62,000. Finally, The Manufacturers Life Insurance Company bought a new stake in shares of 908 Devices in the 2nd quarter worth approximately $77,000. Institutional investors own 88.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on MASS shares. Wall Street Zen downgraded 908 Devices from a “buy” rating to a “hold” rating in a research note on Sunday, June 14th. Weiss Ratings lowered 908 Devices from a “hold (c-)” rating to a “sell (d-)” rating in a report on Monday, May 11th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, 908 Devices has an average rating of “Hold” and a consensus price target of $12.00.

908 Devices Company Profile

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.